Empowering Muscle Empowering Lives
Heart Failure β’ Amyotrophic Lateral Sclerosis β’ Hypertrophic Cardiomyopathy
201 - 500
π° $450M Post-IPO Debt on 2022-06
October 2
201 - 500
Oversee RBQM data management at Cytokinetics for clinical trials.
πΊπΈ United States β Remote
π° $450M Post-IPO Debt on 2022-06
β° Full Time
π Senior
π² Risk
π½ H1B Visa Sponsor
August 29
201 - 500
Lead regulatory labeling for drug candidates in a biopharmaceutical context.
πΊπΈ United States β Remote
π° $450M Post-IPO Debt on 2022-06
β³ Contract/Temporary
π΄ Lead
π Compliance
π½ H1B Visa Sponsor
July 24
201 - 500
Lead product development efforts for innovative muscle therapies addressing cardiac performance.
πΊπΈ United States β Remote
π΅ $275k - $336k / year
π° $450M Post-IPO Debt on 2022-06
β³ Contract/Temporary
π΄ Lead
π¨ββοΈ Medical Director
π½ H1B Visa Sponsor